Press "Enter" to skip to content

Analysis of Europe Dipeptide Peptidase 4 (DPP-4) inhibitors Market 2019-2024: Industry Trends, Share, Size, Price, Revenue, Business Strategy, Production Technology Forecast to 2024

Europe

The “Europe Dipeptide Peptidase 4 (DPP-4) inhibitors Market” research report 2019-2024 delivers comprehensive information and valuable insights about the Europe Dipeptide Peptidase 4 (DPP-4) inhibitors industry. The information available in the Europe Dipeptide Peptidase 4 (DPP-4) inhibitors market report is not only based on the facts but also on the case studies, which analysts have included to convey appropriate information to the clients in a well-versed manner. Europe Dipeptide Peptidase 4 (DPP-4) inhibitors market report includes valuable information to assist new entrants, as well as established players, to understand the prevailing trends in the market.

Some Companies Are Covered in the Europe Dipeptide Peptidase 4 (DPP-4) inhibitors Market:

  • Merck and Co.
  • AstraZeneca
  • Bristol Myers Squibb
  • Novartis
  • Takeda Pharmaceuticals
  • Eli Lilly
  • Boehringer Ingelheim

    Get a Sample Copy of the Report – https://www.industryresearch.co/enquiry/request-sample/14245118

    Market Overview:

  • – The diabetes spending in Europe is 9% of the total healthcare expenditure. Spending on diabetes largely vary among countries in Europe. It ranges from EUR 312 per capita in the Republic of Macedonia, to EUR 6,896 per capita in Norway.
  • – Similarly, the prevalence is also highly varied across Europe, ranging from 2.8% in Albania to 9.8% in Portugal. In high-income countries, diabetes is one of the leading causes of cardiovascular disease, blindness, kidney failure, and lower limb amputation.

    Scope of the Report:

  • The DPP-4 inhibitors market is segmented by brands and covers the following brands, namely, Januvia, Onglyza/Kombiglyze, Tradjenta, Nesina, Galvus, and other brands. The report is segmented by geography.

    Reasons for Buying Europe Dipeptide Peptidase 4 (DPP-4) inhibitors Market Report:

    • This report provides pin-point analysis for changing competitive dynamics
    • It provides a forward looking perspective on different factors driving or restraining market growth
    • It provides a five-year forecast assessed on the basis of how the market is predicted to grow
    • It helps in understanding the key product segments and their future
    • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
    • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

    For More Information or Query or Customization Before Buying, Visit at – https://www.industryresearch.co/enquiry/pre-order-enquiry/14245118

    Key Market Trends:

    Januvia Had Registered a Negative CAGR in the Historic Period.

    – The DPP-4 inhibitor drugs are Tradjenta (linagliptin), Onglyza (saxagliptin), Januvia (sitagliptin), Nesina (Alogliptin), and Glavus(Vildagliptin). The European DPP-4 market is expected to register a CAGR of 4.9%, over the forecast period (2018-2023).
    – Januvia holds the highest share in the DPP-4 market. However, it is expected to decrease during the forecast period, and Tradjenta is expected to gain market share, due to increased efficacy.
    – The market value for Januvia had registered negative CAGR in the European region, due to the decrease in global revenue of drug. Additionally, it is facing pricing pressure due to higher discounts and rebates to maintain good managed care coverage in Europe.

    Europe Dipeptide Peptidase 4 (DPP-4) Inhibitors Market is Expected to Register a CAGR of 3.8%

    – The market is directly proportional to the growing type 2 diabetic population. In most of the cases, DPP-4 are the second line of drugs prescribed for type 2 patients.
    – Over the years, the European diabetic population increased tremendously, and type 2 population accounts for almost 90% of the diabetic population. The growth in diabetic population is due to it being a lifestyle disease.

    Europe Dipeptide Peptidase 4 (DPP-4) inhibitors Market Report Provides Comprehensive Analysis of:

    • Functional market industry outline
    • Up and downstream industry examination
    • Channels and propositions believability
    • Market challenge by key players
    • Enhancement suggestions examination

    Purchase this Report (Price 4000 USD for single user license) – https://www.industryresearch.co/purchase/14245118

    Report Highlights:

    • Market Dynamics – Drivers, Restraints, and Opportunities
    • Market Segmentation – Types, Applications, Regions, and Technology
    • Market Trends
    • Competitive Landscape
    • SWOT Analysis and Porter’s Five Forces Analysis

    Detailed TOC of Europe Dipeptide Peptidase 4 (DPP-4) inhibitors Market Report 2019-2024:

    1 INTRODUCTION
    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study

    2 RESEARCH METHODOLOGY

    3 EXECUTIVE SUMMARY

    4 MARKET DYNAMICS
    4.1 Market Overview
    4.2 Drivers
    4.3 Restraints
    4.4 Porter’s Five Forces Analysis
    4.4.1 Bargaining Power of Suppliers
    4.4.2 Bargaining Power of Consumers
    4.4.3 Threat of New Entrants
    4.4.4 Threat of Substitute Products and Services
    4.4.5 Intensity of Competitive Rivalry

    5 MARKET SEGMENTATION
    5.1 By Drug
    5.1.1 Dipeptidyl Peptidase – 4 (DPP-4) Inhibitors (Value and Volume, 2012-2024)
    5.1.1.1 Januvia (Sitagliptin)
    5.1.1.2 Onglyza (Saxagliptin)
    5.1.1.3 Tradjenta (Linagliptin)
    5.1.1.4 Vipidia/Nesina (Alogliptin)
    5.1.1.5 Galvus (Vildagliptin)
    5.1.1.6 Other DPP – 4 Drugs
    5.2 Geography
    5.2.1 Europe
    5.2.1.1 France (Value and Volume, 2012-2024)
    5.2.1.1.1 By Drug (Januvia, Onglyza, Tradjenta, Vipidia, Galvus)
    5.2.1.1.2 By Company (Merck, AstraZeneca, Novartis, Eli Lilly & Boehringer Ingelheim, Takeda Pharmaceutical)
    5.2.1.2 Germany (Value and Volume, 2012-2024)
    5.2.1.2.1 By Drug (Januvia, Onglyza, Tradjenta, Vipidia, Galvus)
    5.2.1.2.2 By Company (Merck, AstraZeneca, Novartis, Eli Lilly & Boehringer Ingelheim, Takeda Pharmaceutical)
    5.2.1.3 Italy (Value and Volume, 2012-2024)
    5.2.1.3.1 By Drug (Januvia, Onglyza, Tradjenta, Vipidia, Galvus)
    5.2.1.3.2 By Company (Merck, AstraZeneca, Novartis, Eli Lilly & Boehringer Ingelheim, Takeda Pharmaceutical)
    5.2.1.4 Spain (Value and Volume, 2012-2024)
    5.2.1.4.1 By Drug (Januvia, Onglyza, Tradjenta, Vipidia, Galvus)
    5.2.1.4.2 By Company (Merck, AstraZeneca, Novartis, Eli Lilly & Boehringer Ingelheim, Takeda Pharmaceutical)
    5.2.1.5 United Kingdom (Value and Volume, 2012-2024)
    5.2.1.5.1 By Drug (Januvia, Onglyza, Tradjenta, Vipidia, Galvus)
    5.2.1.5.2 By Company (Merck, AstraZeneca, Novartis, Eli Lilly & Boehringer Ingelheim, Takeda Pharmaceutical)
    5.2.1.6 Russia (Value and Volume, 2012-2024)
    5.2.1.6.1 By Drug (Januvia, Onglyza, Tradjenta, Vipidia, Galvus)
    5.2.1.6.2 By Company (Merck, AstraZeneca, Novartis, Eli Lilly & Boehringer Ingelheim, Takeda Pharmaceutical)
    5.2.1.7 Rest of Europe (Value and Volume, 2012-2024)
    5.2.1.7.1 By Drug (Januvia, Onglyza, Tradjenta, Vipidia, Galvus)
    5.2.1.7.2 By Company (Merck, AstraZeneca, Novartis, Eli Lilly & Boehringer Ingelheim, Takeda Pharmaceutical)

    6 MARKET INDICATORS
    6.1 Type-1 Diabetes Population (2012-2024)
    6.2 Type-2 Diabetes Population (2012-2024)

    7 COMPETITIVE LANDSCAPE
    7.1 Company Profiles
    7.1.1 Merck and Co.
    7.1.2 AstraZeneca
    7.1.3 Bristol Myers Squibb
    7.1.4 Novartis
    7.1.5 Takeda Pharmaceuticals
    7.1.6 Eli Lilly
    7.1.7 Boehringer Ingelheim
    7.2 Company Share Analysis
    7.2.1 Merck and Co.
    7.2.2 AstraZeneca
    7.2.3 Takeda Pharmaceuticals
    7.2.4 Novartis
    7.2.5 Eli Lilly & Boehringer Ingelheim

    8 MARKET OPPORTUNITIES AND FUTURE TRENDS

     

    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Physical Vapor Deposition Market 2019 Offers Newest Industry Data, Industry Future Trends, Sales, Revenue, Growth Rate by Types and Applications Forecast till 2023

    Child Car Seats Market 2019 Global Industry Size, Outlook, Share, Demand, Manufacturers and 2024 Forecast Research’s

    Mobile Hotspots Market 2019 Global Industry Trends, Size, Segments, Competitors Strategy, Regional Analysis, Review, Key Players Profile, Statistics and Growth to 2025 Analysis

    Global Fold down beds Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2025

  • Be First to Comment

    Leave a Reply

    Your email address will not be published.